153 related articles for article (PubMed ID: 37495012)
1. A deep dive into historical Ames study data for N-nitrosamine compounds.
Tennant RE; Ponting DJ; Thresher A
Regul Toxicol Pharmacol; 2023 Sep; 143():105460. PubMed ID: 37495012
[TBL] [Abstract][Full Text] [Related]
2. Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity data.
Thresher A; Foster R; Ponting DJ; Stalford SA; Tennant RE; Thomas R
Regul Toxicol Pharmacol; 2020 Oct; 116():104749. PubMed ID: 32777431
[TBL] [Abstract][Full Text] [Related]
3. Ames test study designs for nitrosamine mutagenicity testing: qualitative and quantitative analysis of key assay parameters.
Thomas DN; Wills JW; Tracey H; Baldwin SJ; Burman M; Williams AN; Harte DSG; Buckley RA; Lynch AM
Mutagenesis; 2024 Mar; 39(2):78-95. PubMed ID: 38112628
[TBL] [Abstract][Full Text] [Related]
4. Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines.
Trejo-Martin A; Bercu JP; Thresher A; Tennant RE; Thomas RF; Cross K; Czich A; Waese K; Nicolette JJ; Murray J; Sonders P; Kondratiuk A; Cheung JR; Thomas D; Lynch A; Harvey J; Glowienke S; Custer L; Escobar PA
Regul Toxicol Pharmacol; 2022 Nov; 135():105247. PubMed ID: 35998738
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of different pairs of DNA repair-deficient and DNA repair-proficient bacterial tester strains for rapid detection of chemical mutagens and carcinogens.
Suter W; Jaeger I
Mutat Res; 1982 Feb; 97(1):1-18. PubMed ID: 6799822
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic impurities in pharmaceuticals: A critical assessment of the cohort of concern with a focus on N-nitrosamines.
Snodin DJ
Regul Toxicol Pharmacol; 2023 Jun; 141():105403. PubMed ID: 37116739
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency.
Snodin DJ; Trejo-Martin A; Ponting DJ; Smith GF; Czich A; Cross K; Custer L; Elloway J; Greene N; Kalgutkar AS; Stalford SA; Tennant RE; Vock E; Zalewski A; Ziegler V; Dobo KL
Chem Res Toxicol; 2024 Feb; 37(2):181-198. PubMed ID: 38316048
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicity.
Kamber M; Flückiger-Isler S; Engelhardt G; Jaeckh R; Zeiger E
Mutagenesis; 2009 Jul; 24(4):359-66. PubMed ID: 19447896
[TBL] [Abstract][Full Text] [Related]
9. Resolution of contradiction between in silico predictions and Ames test results for four pharmaceutically relevant impurities.
Gunther WC; Kenyon MO; Cheung JR; Dugger RW; Dobo KL
Regul Toxicol Pharmacol; 2017 Dec; 91():68-76. PubMed ID: 29061373
[TBL] [Abstract][Full Text] [Related]
10. Mini mutagenicity test: a miniaturized version of the Ames test used in a prescreening assay for point mutagenesis assessment.
Flamand N; Meunier J; Meunier P; Agapakis-Caussé C
Toxicol In Vitro; 2001 Apr; 15(2):105-14. PubMed ID: 11287170
[TBL] [Abstract][Full Text] [Related]
11. Maximizing use of existing carcinogenicity data to support acceptable intake levels for mutagenic impurities in pharmaceuticals: Learnings from N-nitrosamine case studies.
Felter SP; Ponting DJ; Mudd AM; Thomas R; Oliveira AAF
Regul Toxicol Pharmacol; 2023 Sep; 143():105459. PubMed ID: 37474097
[TBL] [Abstract][Full Text] [Related]
12. Genotoxicity evaluation of a valsartan-related complex N-nitroso-impurity.
Glowienke S; Onken U; Elhajouji A; Muthusamy S; Sangana R; Martus HJ; Bedman T; Hartmann A
Regul Toxicol Pharmacol; 2022 Oct; 134():105245. PubMed ID: 35988810
[TBL] [Abstract][Full Text] [Related]
13. The micro-Ames test: A direct comparison of the performance and sensitivities of the standard and 24-well plate versions of the bacterial mutation test.
Proudlock R; Evans K
Environ Mol Mutagen; 2016 Dec; 57(9):687-705. PubMed ID: 27862311
[TBL] [Abstract][Full Text] [Related]
14. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
Kirkland D; Reeve L; Gatehouse D; Vanparys P
Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
[TBL] [Abstract][Full Text] [Related]
15. Bacterial mutagenicity assays: Vehicle and positive control results from the standard Ames assay, the 6- and 24-well miniaturized plate incorporation assays and the Ames II™ assay.
Pant K; Bruce S; Sly J; Klug Laforce M; Springer S; Cecil M; Andrus E; Dakoulas E; Wagner VO; Hewitt NJ; Kulkarni R
Environ Mol Mutagen; 2016 Jul; 57(6):483-96. PubMed ID: 27198925
[TBL] [Abstract][Full Text] [Related]
16. Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s.
Li X; He X; Le Y; Guo X; Bryant MS; Atrakchi AH; McGovern TJ; Davis-Bruno KL; Keire DA; Heflich RH; Mei N
Arch Toxicol; 2022 Nov; 96(11):3077-3089. PubMed ID: 35882637
[TBL] [Abstract][Full Text] [Related]
17. The mutagenicity of 45 nitrosamines in the Salmonella typhimurium.
Andrews AW; Lijinsky W
Teratog Carcinog Mutagen; 1980; 1(3):295-303. PubMed ID: 6119819
[TBL] [Abstract][Full Text] [Related]
18. Potentially mutagenic impurities: analysis of structural classes and carcinogenic potencies of chemical intermediates in pharmaceutical syntheses supports alternative methods to the default TTC for calculating safe levels of impurities.
Galloway SM; Vijayaraj Reddy M; McGettigan K; Gealy R; Bercu J
Regul Toxicol Pharmacol; 2013 Aug; 66(3):326-35. PubMed ID: 23688841
[TBL] [Abstract][Full Text] [Related]
19. High mutagenic activity of N-nitrosobis(2-oxopropyl)amine and N-nitrosobis(2-hydroxypropyl)amine in the host-mediated assay in hamsters: evidence for premutagenic methyl and hydroxylpropyl adducts.
Guttenplan JB; Kokkinakis D
Carcinogenesis; 1993 Aug; 14(8):1621-5. PubMed ID: 8353845
[TBL] [Abstract][Full Text] [Related]
20. Mutagenicity of nitrosamines in methyltransferase-deficient strains of Salmonella typhimurium coexpressing human cytochrome P450 2E1 and reductase.
Cooper MT; Porter TD
Mutat Res; 2000 Nov; 454(1-2):45-52. PubMed ID: 11035158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
